摘要
目的探讨中药汤剂雾化吸入在辅助治疗耐药肺结核中的作用与治疗效果。方法选取2013年6月至2013年11月在我院诊治的耐药肺结核120例,随机分2组,A组采取氧驱动雾化吸入中药汤剂(抗痨汤Ⅰ号)联合常规治疗,B组采取单纯常规治疗,对2组治疗过程中的临床症状变化及治疗效果进行对比分析。结果 A组与B组的治疗效果分别为:症状缓解率为98%和93%,痰菌转阴率为78%和61%,病灶显著吸收好转率为96%和85%,2组差别明显(P<0.05)。结论化疗辅以雾化吸入抗痨汤Ⅰ号治疗耐药性肺结核,有助于较快地缓解临床症状,缩短病菌转阴时间,加速病灶吸收。
Objective To study the role of the traditional Chinese medicine broth atomization inhalation in adjuvant theraping drug resistant of tuberculosis and to evaluate the efficacy of the treatment .Methods 120 cases were selected in Hebei Province Chest Hospital who had been diagnosed as drug resistant tuberculosis from June to November 2013 .Then the cases were divided into two groups randomly ,group A and group B .Group A took oxygen atomization inhalation of traditional Chinese medicine broth (chemotherapy soup Ⅰ) with conventional therapy ,while group B took simple routine therapy .The clinical symptom and treat‐ment effect of the two groups were analyzed and compared .Results Group A and group B′s symptom remission rate were 98%and 93% ,respectively ,and sputum bacteria turn rate in group A ,group B were 78% and 61% ,respectively .Lesions were sig‐nificantly absorbed ,the group A was 96% ,and group B was 85% .The two groups showed difference (P〈 0 .05) .Conclu‐sion Chemotherapy with atomization inhalation treatment of drug‐resistant tuberculosis chemotherapy ,soup Ⅰ ,is effective in re‐living the clinical symptoms .
出处
《西北药学杂志》
CAS
2015年第3期287-289,共3页
Northwest Pharmaceutical Journal
基金
河北省中医药管理局基金资助项目(编号:2013062)
关键词
雾化吸入
抗痨汤Ⅰ号
耐药肺结核
疗效分析
atomization inhalation
the chemotherapy soup I
drug-resistant tuberculosis
curative effect analysis